Articles related to LUNG CANCER

Explore the indicators of lung cancer, including persistent cough and unexplained weight loss, which may help in its early detection and improve patient outcomes.

Explore the latest advancement in NSCLC treatment: the FDA-approved amivantamab combo has demonstrated a significant leap in progression-free survival for patients with specific genetic mutations, reshaping the standard of care.

In a sobering case from the Omaha VA Medical Center, the failure to follow up on a lung nodule resulted in a veteran’s preventable late-stage lung cancer, highlighting the imperative for rigorous oversight in patient care tracking systems.

In an alarming case at the Omaha VA Medical Center, a year-long gap in monitoring the lung imaging registry led to serious patient care oversights, including a veteran’s undiagnosed lung cancer progression. This incident highlights the critical need for continuous and vigilant monitoring in healthcare systems.

In the CodeBreaK 100 study, a lower 240 mg dose of sotorasib demonstrated similar efficacy to the FDA-approved 960 mg dose in treating KRAS G12C–mutated NSCLC, with potentially fewer severe adverse events.

UT Southwestern’s pioneering use of SCINTIX biology-guided radiotherapy represents a major advancement in precision oncology, targeting bone and lung cancers with a novel approach that combines PET imaging and radiotherapy for more effective treatment.